Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $24

Benzinga Newsdesk www.benzinga.com Negative 58.3%

Neg 58.3% Neu 0% Pos 0%

Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $28 to $24.